+44-1625-70898
+44-1625-70898
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr. Jianfei Yang is a principal scientist, project leader and immunologist at Tempero, GlaxoSmithKline, in Cambridge, MA, USA. He received a PhD in Pathology from Niigata University in Japan. He then obtained postdoctoral training in Dr. Ken Murphy’s lab at HHMI and Washington University. In the past 18 year, he has been studying the role of CD4+ T helper cells in immunity and diseases. He has 14 years of experience in immuno-inflammatory disease research and pharmaceutical drug development. He has published numerous papers and patents. He has been recognized as an expert in Th17 research and drug development in pharmaceutical industry.
Jianfei Yang’s research interests include the role of immune cells such as Th17 and Treg cells in innate and protective immunity, autoimmune and inflammatory diseases, and cancers. He is interested in drug discovery of small molecule and novel therapeutic monoclonal antibodies for the treatment of various diseases. He is also interested in immunotherapy for tumor and inflammatory diseases.
| Jianfei Yang, Jill Skepner, Mark Trocha and Shomir Ghosh |
| Editorial: J Clin Cell Immunol 2013, 4: e111 |
| DOI: 10.4172/2155-9899.1000e111 |
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
